SEC Form 4 · accession 0001209191-17-003537
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jacques Gonella
Director
Period of report
Dec 30, 2016
Accepted (ET)
Jan 12, 2017 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 30, 2016 | J | 2,900,000 | $0.00 | A | 12,026,413 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares previously owned indirectly through Vecap Venture Capital Partners, AG ("Vecap Venture") which were transferred directly to Dr. Gonella. Dr. Gonella has a controlling interest in Vecap Venture.